Cargando…
Comorbidities, biomarkers and cause specific mortality in patients with irritable bowel syndrome: A phenome‐wide association study
BACKGROUND: Irritable bowel syndrome (IBS) is one of the most common functional digestive disorders. Our understanding about its comorbidities, biomarkers, or long‐term risks is still incomplete. OBJECTIVE: To characterize comorbidities and biomarkers for IBS and establish the effect of IBS on overa...
Autores principales: | Seeling, Katharina Sophie, Hehl, Leonida, Vell, Mara Sophie, Rendel, Miriam Daphne, Creasy, Kate Townsend, Trautwein, Christian, Mehler, David Marc Anton, Keszthelyi, Daniel, Schneider, Kai Markus, Schneider, Carolin Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10256994/ https://www.ncbi.nlm.nih.gov/pubmed/37151116 http://dx.doi.org/10.1002/ueg2.12397 |
Ejemplares similares
-
Omega-3 intake is associated with liver disease protection
por: Vell, Mara Sophie, et al.
Publicado: (2023) -
A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome
por: Weerts, Zsa Zsa R. M., et al.
Publicado: (2021) -
Aspirin is associated with a reduced incidence of liver disease in men
por: Vell, Mara Sophie, et al.
Publicado: (2023) -
Association between Brachyspira and irritable bowel syndrome with diarrhoea
por: Jabbar, Karolina S, et al.
Publicado: (2021) -
Epithelial expression and function of trypsin-3 in irritable bowel syndrome
por: Rolland-Fourcade, Claire, et al.
Publicado: (2017)